glp-1 for bulimia GLP-1RAs and Obesity Associated with Eating Disorders GLP-1 medications are changing medicine

Hansotia, T

[DOI] [PMC free article] [PubMed] [Google Scholar] 61.Hummel SL, Seymour EM, Brook RD, et al

Madison is a board-certified Family Nurse Practitioner with a bachelor's degree of Science in Nursing from Saint Louis University and a Master's degree of Science in Nursing from Belmont University

It is composed of two domains, one transmembrane (TMD) domain that binds the N-terminal region of GLP-1 and the extracellular (ECD) that binds the C-terminal helix of GLP-1

Real support

Earlier medications such as topiramate and sympathomimetic agents like phentermine have shown short-term weight loss benefits, but their use is often restricted due to side effects including fatigue, memory impairment, insomnia, and elevated cardiovascular risk